Tanya Samazan[email protected]Trends and FinancePCR-based life science tools top $5B, with digital PCR showing rapid growth: SDi reportAmong the PCR technologies for the life sciences laboratory tools industry, dPCR is the fastest growing, as evidenced by the recent market entry of large qPCR vendors.December 6, 2022InfectiousCOVID-19-related sales remain strong for lab tool firms in 2021Thermo Fisher ScientificDecember 8, 2021Page 1 of 1Top StoriesFDA ClearanceAmgen gets FDA approval for small cell lung cancer therapyAmgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).Artificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisStockT2 Biosystems to sell $8M in stock in private placementFDA Warning LetterFDA issues warning for Cue Health COVID-19 testsSponsor ContentVisit our Molecular Diagnostics Community